Paramagnetic metalloporphyrins: Infarct avid contrast agents for diagnosis of acute myocardial infarction by MRI

European Radiology

Volumn 6, Issue 1, 1996, Pages 2-8

  Marchal, G ^a   Ni, Y ^a   Herijgers, P ^a   Flameng, W ^a   Petre C ^a   Bosmans, H ^a   Yu, J ^a   Ebert, W ^b   Hilger, C S ^b   Pfefferer, D ^b   Semmler, W ^b   Baert, A L ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b Forschungs institut für Respiratorische Diagnostik   (Germany)

Author keywords

Contrast media; Metalloporphyrins; MRI; Myocardial infarction; Necrosis

Indexed keywords

COLORING AGENT; CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM; MANGANESE; MANGANESE TETRAPHENYLPORPHYRIN; MESOPORPHYRIN; METALLOPORPHYRIN; TETRAZOLIUM; TRIPHENYLTETRAZOLIUM;

ANIMAL; ARTICLE; CYTOCHEMISTRY; ELECTRON SPIN RESONANCE; HEART INFARCTION; HEART MUSCLE; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; METHODOLOGY; NECROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RAT; SPECTROSCOPY; WISTAR RAT;

ANIMALS; COLORING AGENTS; CONTRAST MEDIA; ELECTRON SPIN RESONANCE SPECTROSCOPY; GADOLINIUM; HISTOCYTOCHEMISTRY; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MANGANESE; MESOPORPHYRINS; METALLOPORPHYRINS; MYOCARDIAL INFARCTION; MYOCARDIUM; NECROSIS; RATS; RATS, WISTAR; SPECTRUM ANALYSIS; TETRAZOLIUM SALTS;

EID: 0029690829     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00619942     Document Type: Article

References (31)

1. American Heart Association (1989) 1990 heart and stroke facts. American Heart Association, Dallas, TX, USA pp 1-44
2. Roberts R, Kleiman NS (1994) Earlier diagnosis and treatment of acute myocardial infarction necessitates the need for a "new diagnostic mind-set". Circulation 89: 872-881
3. Kaul S, Pandian NG, Gillam LD et al. (1986) Contrast echocardiography in acute myocardial ischemia: III. An in-vivo comparison of the extent of abnormal wall motion with the "area at risk" for necrosis. J Am Coll Cardiol 7: 383-392
4. Zaret BL, Wackers FJ (1993) Nuclear cardiology (review). N Engl J Med 329: 775-783
5. Johnston D, Thompson R, Liu P (1986) Magnetic resonance imaging during acute myocardial infarction. Am J Cardiol 58: 214-219
6. Saeed M, Wendland M, Takehara Y, Masui T, Higgins C (1992) Reperfusion and irreversible myocardial injury: identification with a nonionic MR imaging contrast medium. Radiology 182: 675-683
7. Weissleder R, Lee A, Khaw BN, Shen T, Brady T (1992) Antimyosin-labeled monocrystalline iron oxide allows detection of myocardial infarct: MR antibody imaging. Radiology 182: 381-385
8. Nelson J, Schmiedl U, Shankland E (1990) Metalloporphyrins as tumor-seeking MRI contrast media and as potential selective treatment sensitizers. Invest Radiol 25: S71-S73
9. Ogan M, Revel D, Brasch R (1987) Metalloporphyrin contrast enhancement of tumors in magnetic resonance imaging. A study of human carcinoma, lymphoma, and fibrosarcoma in mice. Invest Radiol 22: 822-828
10. van Zijl PCM, Place DA, Cohen JS, Faustino PJ, Lyon RC, Patronas NJ (1990) Metalloporphyrin magnetic resonance contrast agents: feasibility of tumor-specific magnetic resonance imaging. Acta Radiol Suppl (Stockh) 374: 75-79
11. Hindre F, LePlouzennec M, Certaines JD de, Foultier MT, Patrice T, Simonneaux G (1993) Tetra-p-amonophenylporphyrin conjugated with Gd-DTPA: tumor-specific contrast agent for MR imaging. J Magn Reson Imaging 3(1): 59-65
12. Young SW, Sidhu MK, Qing F, Muller HH, Neuder M, Zanassi G, Mody T, Hammi G, Dow W, Mutch JD, Sessler JL, Miller RA (1994) Preclinical evaluation of gadolinium (III) texaphyrin complex: a new paramagnetic contrast agent for magnetic resonance imaging. Invest Radiol 29: 330-338
13. Hilger CS, Maier FK, Ebert W, Lee-Vaupel M, Niedballa U, Gaida J, Conrad J. German patent DE 42 32 925 A1, September 28, 1992
14. Maier FK, Ebert W, Lee-Vaupel M, Conrad J, Gries H. German patent DE 43 05 523 A1, February 17, 1993
15. Ni Y, Marchal G, Yu J, Lukito G, Petré C, Wevers M, Baert AL, Ebert W, Hilger CS, Maier FK, Semmler W (1995) Localization of metalloporphyrin induced "specific" enhancement in experimental liver tumors: comparison of MRI, microangiographic and histologic findings. Acad Radiol 2: 687-699
16. Ni Y (1995) Development and application of a methodology for preclinical evaluation of tissue specific MRI contrast media. Dissertation of the Ph.D. degree, Faculty of Medicine, Katholieke Universiteit Leuven, Belgium
17. Selye H, Bajusz E, Grasso S, Mendell P (1960) Simple technique for the surgical occlusion of coronary vessels in the rat. Angiology 11: 398-407
18. Fishbein M, Meerbaum S, Rit J, Lando U, Kanmatsuse K, Mercier M (1981) Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J 101: 593-600
19. Saeed M, Wendland M, Masui T, Yu KK, Li J, Derugin N, Higgins CB (1993) Dual mechanisms for change in myocardial signal intensity by means of a single MR contrast medium: dependence on concentration and pulse sequence. Radiology 186: 175-182
20. Goldman MR, Brady TJ, Pykett IL, Burt CT, Buonanno FS, Kistler JP, Newhouse JH, Hinshow WS, Pohost GM (1982) Quantifications of experimental myocardial infarction using nuclear magnetic resonance imaging and paramagnetic ion contrast enhancement in exciseal canine hearts. Circulation 66: 1012-1016
21. Karlson BW, Herlitz J, Wiklund O et al. (1991) Early prediction of acute myocardial infarction from clinical history, examination, and electrocardiogram in the emergency room. Am J Cardiol 68: 171-175
22. Apple FS (1992) Acute myocardial infarction and coronary reperfusion: serum cardiac markers for the 1990s. Am J Clin Pathol 97: 85-89
23. Flameng W, Lesaffre E, Vanhaecke J (1990) Determinants of infarct size in non-human primates. Basic Res Cardiol 85: 392-403
24. Rahimtoola SH (1989) The hibernating myocardium. Am Heart J 117: 211-221
25. Braunwald E, Kloner RA (1982) The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 66: 1146-1149
26. Bergman SR (1991) Positron emission tomography of the heart. In: Gerson MC (eds) Cardiac nuclear medicine, 2nd edn. McGraw-Hill, New York, pp 299-336
27. Adzamli IK, Blau M, Pfeffer MA, Davis MA (1993) Phosphonate-modified Gd-DTPA complexes. III: the detection of myocardial infarction by MRI. Magn Reson Med 29: 505-511
28. McNamara MT, Higgins CB, Ehman RL, Revel D, Sievers R, Brasch RC (1984) Acute myocardial ischemia: magnetic resonance contrast enhancement with gadolinium-DTPA. Radiology 153: 157
29. Schmiedl U, Moseley M, Sievers R, Organ MD, Chew WM, Engeseth H, Finfbeiner WE, Lipton MJ, Brasch RC (1987) Magnetic resonance imaging of myocardial infarction using albumin-(Gd-DTPA), a macromolecular blood-volume contrast agent in a rat model. Invest Radiol 22: 713-721
30. Khaw BA, Strauss HW, Moore R, Fallon JT, Yasuda T, Gold HK, Haber E (1987) Myocardial damage delineated by indium-111 antimyosin Fab and technetium-99m pyrophosphate. J Nucl Med 28: 76-82
31. Nelson J, Schmiedl U (1991) Porphyrins as contrast media. Magn Reson Med 22: 366-371